Limfa Therapy System (Limfa Therapy)— 510(k) K243165
Substantially EquivalentEywa Srl
FDA 510(k) clearance K243165 for Limfa Therapy System (Limfa Therapy), Substantially Equivalent on 2025-05-15. Applicant: Eywa Srl. Device class: 2.
Clearance details
- Applicant
- Eywa Srl
- Product code
- Code NGX
- Device class
- Class 2
- Regulation
- 21 CFR 890.5850
- Advisory panel
- Physical Medicine
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Rimini, IT
Recent devices under product code NGX
view allData sourced from openFDA. This site is unofficial and independent of the FDA.